48 results on '"Filippatos, Gerasimos"'
Search Results
2. Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial
3. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
4. Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency
5. Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure
6. Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection Fraction
7. Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure With Reduced Ejection Fraction
8. Variation Of Prespecified Subgroups In Large-Scale HF Outcome Trials
9. Safety Indicators In Patients Receiving High-intensity Care After Acute Heart Failure Admission: The STRONG-HF Trial
10. Autonomic Regulation Therapy To Improve Symptoms And Clinical Outcomes In Patients With Heart Failure And Reduced Ejection Fraction (ANTHEM-HFrEF) Pivotal Study Results
11. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy
12. Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure
13. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
14. Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial
15. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
16. Utility of Urine Neutrophil Gelatinase-Associated Lipocalin for Worsening Renal Function during Hospitalization for Acute Heart Failure: Primary Findings of the Urine N-gal Acute Kidney Injury N-gal Evaluation of Symptomatic Heart Failure Study (AKINESIS)
17. Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry
18. Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock
19. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
20. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
21. Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency
22. Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure
23. Minimal Clinically Important Difference for Six-minute Walk Test in Patients with HFrEF and Iron Deficiency.
24. Minimal Clinically Important Difference for Six-minute Walk Test in Patients with HFrEF and Iron Deficiency
25. Patiromer Enables The Initiation Of Mineralocorticoid Receptor Antagonists (MRAs) For Heart Failure With Reduced Ejection Fraction (HFrEF) In Patients With Hyperkalemia (HK) Or Previous HK: Post HocAnalysis Of The DIAMOND Trial
26. Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure
27. Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure with Reduced Ejection Fraction
28. The Rationale for an Acute Heart Failure Syndromes Clinical Trials Network
29. Reduction in Circulating Testosterone Relates to Exercise Capacity in Men With Chronic Heart Failure
30. Updated Clinical Practice Guidelines on Heart Failure: An International Alignment
31. Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF)
32. Management of Atrial Fibrillation in Patients With Heart Failure
33. Prognostic Value of Blood Urea Nitrogen in Patients Hospitalized With Worsening Heart Failure: Insights From the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) Study
34. Carvedilol Improves Left Atrial and Left Ventricular Function and Reserve in Dilated Cardiomyopathy After 1 Year of Treatment
35. Clinical Predictors of QRS Duration in Patients with LBBB: Data from the AdaptResponse Trial
36. Association between Left Ventricular Ejection Fraction and Worsening Renal Function in Acute Heart Failure: Insights from the RELAX-AHF-2 Trial
37. Influence of Gender and Copeptin Levels on Clinical Outcomes in Patients With Acute Heart Failure
38. Design and Rationale of the Soluble Guanylate Cyclase Stimulator in Heart Failure Studies (SOCRATES)
39. Acute Heart failure: Update 2013
40. 075 - Influence of Gender and Copeptin Levels on Clinical Outcomes in Patients With Acute Heart Failure
41. Treatment of acute decompensated heart failure with the soluble guanylate cyclase activator cinaciguat: The COMPOSE program – three randomized, controlled, phase IIb studies
42. Functional Electrical Stimulation is More Effective in Severe Symptomatic Heart Failure Patients and Improves Their Adherence to Rehabilitation Programs
43. Changes in Dyspnea during Treatment of Acute Heart Failure Are Correlated with Clinical Signs, Rehospitalizations and Mortality. Results from the Pre-RELAX-AHF Trial
44. Time to Treatment and Vasodilator Efficacy in Acute Heart Failure: Results from the Pre-RELAX-AHF Study
45. Vasopressin Antagonists for the Treatment of Acute Decompensated Heart Failure: When, for Whom, for How Long, and on What Standard Therapy?
46. Prognostic Value of Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure (CHF)
47. Levosimendan, Compared to Dobutamine, Reduces Enzymatic Markers Associated with Liver Congestion and Right Heart Failure: A SURVIVE Subanalysis
48. Dissociation of Patient and Physician Assessed Symptoms during Hospitalization for Acute Heart Failure: The Measure-HF Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.